IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536105. A total of 42 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q2 2014. The put-call ratio across all filers is 7.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $246,000 | -58.2% | 2,089,101 | -18.4% | 0.00% | – |
| Q2 2016 | $589,000 | -20.6% | 2,558,874 | 0.0% | 0.00% | – |
| Q1 2016 | $742,000 | -18.8% | 2,558,874 | -0.5% | 0.00% | – |
| Q4 2015 | $914,000 | -99.3% | 2,572,374 | -72.4% | 0.00% | -100.0% |
| Q3 2015 | $130,903,000 | +10845.1% | 9,317,296 | +267.7% | 0.01% | – |
| Q2 2015 | $1,196,000 | +1.6% | 2,534,220 | +4.4% | 0.00% | – |
| Q1 2015 | $1,177,000 | -7.8% | 2,426,257 | +38.7% | 0.00% | – |
| Q4 2014 | $1,277,000 | -15.1% | 1,748,657 | +3.4% | 0.00% | – |
| Q3 2014 | $1,505,000 | -18.6% | 1,691,443 | +2.4% | 0.00% | – |
| Q2 2014 | $1,850,000 | -8.2% | 1,651,843 | 0.0% | 0.00% | – |
| Q1 2014 | $2,015,000 | +48.4% | 1,651,843 | +12.5% | 0.00% | – |
| Q4 2013 | $1,358,000 | -61.2% | 1,468,068 | +7.9% | 0.00% | – |
| Q3 2013 | $3,498,000 | +70.6% | 1,360,938 | +28.8% | 0.00% | – |
| Q2 2013 | $2,050,000 | – | 1,056,938 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|